Monday, May 21, 2007

Quick note on XFML

I wanted to highlight a pretty negative piece from Citron on Xinhua Finance Media (NASDAQ:XFML). Make sure you read it before stepping into the stock.

One person rarely makes a co, but these things tend to make investors cautious. I personally still think XFML may be a legit operation. They made Mr. Singhal resign and have appointed a internal committee to review the corporate governance issues. That's definitely good.

Anyway, despite all the negativity it looks like the stock managed to put together a nice bounce after the open. Hope some of you particpated in the move. Would consider taking at least partial profits a prudent move here.

NC

Raymond James: Current valuations in the PV space are highly attractive

- Raymond James notes that over the past two weeks, the solar power space has experienced what is arguably its most significant pullback in at least a year, with the average solar stock down 21% from its year-to-date high as of last Friday. After Aprils gains, the firm thinks this is a healthy pullback. Almost all U.S.-listed solar stocks posted massive gains in April, with some up over 40% in the course of the month. Also, a flurry of IPOs may be pressuring existing issues as the number of publicly traded PV pure-plays on U.S. exchanges has tripled in the past 6 months - from only three as recently as November to nine as of last week (not including several micro-caps).

Much of last Friday's sell-off in the solar space can be attributed to the Chinese central bank's decision to raise interest rates and reserve requirements, in yet another attempt by Beijing to cool down China's surging economy and lofty stock market valuations.

RayJay continues to be very bullish on PV. These short-term stock gyrations aside, they believe that the global PV market is fundamentally in excellent shape and see this pullback as an opportunity to buy on the dip.

Firm believes PV manufacturers naturally stand to benefit, including Outperform-rated

JA Solar Holdings (JASO; currently at only 16.1x their 2008 EPS estimate);

SunPower Corp. (SPWR; at 27.8x 2008E EPS);

Suntech Power Holdings (STP; at 21.4x 2008E EPS);

RayJay views the current valuations as highly attractive within the context of a market growing at 20%+ per year.

Notablecalls: I'm no expert on the PV space but I do consider Raymond James one of the best firms out there. I suspect these comments will create some real buy interest in the mentioned stocks today. My favourite of the three is JASO. Going to call this one actionable.

Xinhua Finance Media (NASDAQ:XFML): Much ado about nothing?

- CIBC is out with some comments on Xinhua Finance Media (NASDAQ:XFML) noting that last week, XFML shares declined 18% during a strong week for China Media stocks. Firm believes weakness in the shares is due to peripheral factors, including the reoccurrence of a nine-year old lawsuit related to the former CFO and management departures at a subsidiary of the parent company.

Over the weekend, the company announced that Mr. Shelly Singhal resigned from its board, after being moved from the CFO to Exec Dir, Corp. Dev., on May 15. Additionally, Barron's reported that two senior staffers at Glass Lewis, a subsidiary of XFML's parent company, had resigned.

The trading pattern of the stock last week suggests that concerns over these two matter were already in the marketplace, even though the news was reported over the weekend.

While these type of events call into question the character of the current and prior mgmt at XFML, CIBC believes these issues have no impact on current fundamentals, and that weakness provides a good buying opportunity ahead of seasonally strong 2Q results. Maintains $14 tgt and Sector Outperformer rating.

Notablecalls: First, let me tell you that XFML isn't a company I know too well. Yet, chewing through some of the initiation notes it certainly looks interesting. The chinese ad industry is in a secular growth phase and it looks like XFML is in a good position to benefit from it. I especially like the co's exposure to the financial media side as numbers coming from China show the chinese people are opening brokerage accounts at a healthy clip.

The news coming over the weekend look bad at first glance but I'm not so sure the impact is as bad as suggested by the decline in XFML's stock price. Also, it looks like a rather large short line was put out over the last week. Trading around 16x 08 EPS, the stock's not exactly expensive.

I would put XFML on my bounce play radar today.

Paperstand (AT, ED, GOOG, CRM, HVT, CONN, MSFT, AAPL)

The WSJ reports that TPG Capital and the private-equity arm of Goldman Sachs last night agreed to purchase Alltel (AT) for about $27.5bn. The deal could signal still more ambitious gambits by buyout shops, which have shown increasing interest in telecom and wireless assets. The buyers will pay about $71.50 per share for the co. That represents a price of about 10% higher than where the shares traded on Fri, and about 23% higher than where its shares traded in late Dec, when The WSJ identified it as a buyout tgt. Top mgmt also has been asked to stay, though they are still "working out the details." Alltel's top 5 execs would get a combined $250m if they were to leave during a change in control.

According to the WSJ, Consolidated Edison (ED) provider of electricity to 9m ppl in NYC and Westchester County, is pursuing a sweeping plan to upgrade its aging electric system, including installation of state-of-the-art superconducting electrical cable in midtown Manhattan. The $39m installation, set to be unveiled today, will be largely funded by the Dept of Homeland Security. Agency officials say they are making the investment b/c the hardiness of electrical infrastructure in financial hubs like Manhattan is vital to the nation's economy. Superconducting cable, sold by several co’s, carries far more power than conventional cable but is expensive and poses certain technical challenges. The Con Edison project will use cable able to deflect power surges that was developed by American Superconductor (AMSC). American Superconductor hopes the marquee project will spur use of the cable by more utilities, which are notoriously cautious about new technology. "We hope this breaks the logjam," said CEO Grey Yurek.

The WSJ reports that Google (GOOG) and Salesforce (CRM) are discussing an alliance that could help them compete more effectively with Microsoft (MSFT). The co’s are still hashing out details of a potential partnership, expected to be announced in the next few weeks. But one outcome could be a Web-based offering that integrates some of Google's online services such as email and IM with those of Salesforce, whose "customer-relationship mgmt" tools help salespeople track their accounts.

“Heard on the Street” reports that national retailers of big-ticket items such as houses, boats and motorcycles aren't the only co’s facing the prospect of more late payments and losses on their consumer loans these days. So, too, are smaller regional retailers. But unlike mortgage lenders, which have been forced to tighten their underwriting standards amid the subprime meltdown, these smaller players are trying to encourage customers to keep buying by offering more zero-interest loans and extended payment plans. "At the end of the day, you do what it takes to get business," says Dennis Fink, CFO of Haverty Furniture (HVT). In the 1Q, 55% of loans that Haverty made to customers were no-interest for longer than 12mo’s, compared with 40% a year earlier. Another co mentioned is Conn’s (CONN).

“Ahead of the Tape” out saying that Microsoft (MSFT) Vista may not meet optimistic views. The tech co that really seems to be enjoying MSFT’s new OS is Apple (AAPL). The co has used Microsoft's Vista as an opportunity to make hay over the self-proclaimed superiority of the OS in its own Macs. Microsoft doesn't agree with that message, noting it has shipped 40m copies of Vista for consumers. Still, Apple has the hotter hand. Mac sales were up 35% in the 1Q. PC sales were up by 9%, a bit better than the prior 2 qrtrs, but below the avg rate of the past 3 years. "Somebody in Cupertino ought to send flowers to Redmond and a nice 'Thank You' note," hedge-fund manager Jeff Matthews noted.

Sunday, May 20, 2007

Barron's Summary

Barron’s out saying that without the burden of Chrysler, Daimler (DCX) stock could continue the rise that began last year. The shares, now around 86, could hit 100 or more in a year. Some savvy investors figure that the new Daimler is still a bargain. "Doing a sum-of-the-parts valuation, Mercedes is in Daimler for free," argues Adam Jonas, of Morgan Stanley, who values that car unit alone at between $30-40 a share.

Fund manager likes COP, AMGN and PFE.

Genworth's (GNW) shares, laggards over the past year, could climb more than 24% over the next 18 to 24 months as the company allocates more capital to higher-return businesses.

USG's (USG) earnings could rebound to $5 or $6 share in coming years. If the company trades again for 15 times earnings - its historic norm - the stock could climb to 90, from today's 40.

Bulls on Clorox (CLX) argue that the stock, now in the high 60s, could go as high as 85 in a year if the company improves its product lineup and starts selling more abroad.

According to the “The Trader” column Rob Haines, of CreditSights, is among those who expects more mergers in life-insurance sector, as co’s look to put money to work. Potential acquirers include American Intl. Group (AIG), which ended last quarter with $15-20bn in excess capital; Prudential (PRU), which has a good merger track record and more than $6bn in untapped debt capacity; and MetLife (MET), which until recently had been busy integrating its Travelers acquisition. Screening for likely targets among co’s with more than $10bn in assets, essentially those with attractive heft but which may lack the scale to compete in the long run, Haines came up with names including Conesco (CNO), Phoenix (PNX), Protective Life (PL) and Unum (UNM). These stocks trade at 0.7-1.5x BV and "could be fairly easy to digest by any one of the larger industry leaders," he notes.

“The Trader” section also highlights Chiquita Brands (CQB), which has found a way to improve one of nature's perfect foods. Working with Landec (LNDC), Chiquita is introducing "intelligent packaging" to extend the shelf life of ripe bananas by up to 12 days. This allows bananas to be sold more widely at convenience stores, fast-food restaurants and Starbucks. It is also rolling out new products like "Chiquita Fruit in a Bottle," which has snagged a 5% share in its first mkt, Belgium. The push to transform the co "from a commodity produce supplier to a more value-added, healthy consumer products co" bodes well for profit growth, says Oppenheimer analyst Barry Sine, who expects per-share earnings to double to $1.50 next year from 75c in ‘07. Given the steps that Chiquita is taking to reduce profit volatility, Oppenheimer's Sine reckons that the co's shares are worth 22. Separately, Landec shares have climbed steadily to about 13.25, up 512% since ‘03, as the co worked off its debt, improved profits and boosted its cash stash to more than $2.25 a share.

“Follow Up” section out saying that Micron (MU) looks cheap. With a tangible book value of about $8.60 a share (including the coming debt), the stock's downside risk is diminishing. It could be 6-9 mo’s before Micron sees profits again, but with spot prices of 512Mb DRAM chips, now around $1.75, approaching the marginal cost of production, price declines will slow. Such low prices, not only for DRAMs but the flash-memory chips that Micron also makes, could lift demand anew, and with it, Micron's shares.

“Sizing Up Small Caps” section discusses regional banks, which are flat in ’07. "The catalyst is not there, at least not yet," to reverse the banks' slide, says David Ellison, of FBR Small Cap Financial Fund. "But you don't know when the catalyst is going to show up," he says, so it's best to purchase reasonably-priced shares in anticipation of the improvement, even if that's a ways off. "As long as you are buying good deposit franchises, you're not going to wake up one day and find out they can't fund themselves," Ellison says. Two banking operations that fit Ellison's description are Cullen/Frost Bankers (CFR) and Seacoast Banking (SBCF). In both cases, the shares have dipped after prolonged gains that some investors believe will resume once the economy picks up and the extent of recent real-estate problems is better defined. Investors in these shares should also benefit from both institutions' attractiveness to bigger players interested in expanding their franchises.

“Technology Trader” section highlights Xinhua Finance Media (XFML), which has collected some influential US assets this year, including Glass Lewis that's staffed with veterans of the SEC and the WSJ...or at least it was until last week. That's when 2 of the most prestigious staffers at Glass Lewis resigned after apparently concluding that their new parent co, Xinhua Finance, would have flunked a Glass Lewis review of its corporate transparency. It turns out that Xinhua Finance's IPO prospectus failed to mention some awkward facts about the co's then-CFO, Shelly Singhal. Singhal was simultaneously the co's CFO and an investment banker and stock broker who runs the Bedrock Securities. And since Apr’06, Singhal's firm has been under a cease- and-desist order from the NASD, as the regulators seek to suspend Bedrock for violating several SEC rules.

“Plugged In” column out saying that it looks like Nokia (NOK) wants to cool off its serious relationship with Texas Instruments (TXN) and start dating other chip suppliers. This isn't a new phenomenon. First, Motorola (MOT) weaned itself from Freescale (FSL), by launching a relationship with Qualcomm (QCOM). Then, in Feb, Nokia announced that Infineon (IFX) would provide a single-chip platform for its entry-level handsets in emerging mkts. TI has been a near-exclusive supplier of power mgmt and baseband chips to Nokia. But it appears that the Infineon deal was only the first blow. Now there's speculation that Nokia is turning to the likes of Freescale and Broadcom (BRCM) to serve as alternative chip suppliers for higher-end handsets. The speculation is that Broadcom will win 2.5G phone business and perhaps some 3G business. "In ‘07, our goal is to win designs. In ‘08, you should start seeing products come out, and ‘09 has to be all about gain in mkt share," CEO of Broadcom, Scott McGregor, told analysts and investors. "You'll see some other products come out later in the year, [but] I can't say too much about them," he said.

Friday, May 18, 2007

AS&E (NYSE:ASEI): Results likely below consensus

- Jefferies comments on AS&E (NYSE:ASEI) saying noting the co reports after the close on Monday and they expect results to belighter than the aggressive consensus estimates of $47 million and$0.80. Backlog should look relatively strong on the surface, but with fewer quick turn-around ZBV orders in backlog the June estimatesare likely also too aggressive.

Assuming decent sequential growth in non-ZBV revenue, firm's analysis suggests the company would need to ship all of its ZBVbacklog in order to possibly reach the consensus March revenueestimate of $47 million. Given we are now in the second half of the June quarter and the company has not announced any ZBV orders, they believe this scenario of shipping all ZBVs in the March quartermay set-up the company for a fairly weak June performance. A shiftaway from higher margin ZBV revenue would likely result in compressed margins and declining earnings.

At 22x firm's C08 EPS estimate they believe there may be some downside should the company miss consensus estimates and theoutlook for growth remains negative. If investor nervousness increases, they would look at 3x $12 cash per share as a good cushion. ASEI likely bottoms in the next few months as the story moves past declining high margin DoD orders for ZBVs. In the second half of 2007 the stability of the business should firm up due to multiple recent longer-term contract awards, enabling healthy sequential growth from June quarter results.

Maintains Underperform and lowers tgt to $40 from $48.

Notablecalls: Looks like some downside in store for ASEI today. But also note that there is fair chance of a nice bounce play after the co reports on Monday as expectations will be quite low.

Under Armour (NYSE:UA): Lots of growth ahead?

- Banc of America reits Buy on Under Armour (NYSE:UA) saying the co could continue to exceed their 30-35% revenue forecast for the balance of 2007 given 1) a likely re-acceleration in women's revenue growth to 30%-plus (following just 17% growth in 1Q07) as 1Q product sourcing shortfalls are corrected and the first UA women's targeted ad campaign kicks in this summer (expected to be larger than the 'Click-Clack' campaign); 2) the launch of more targeted outdoor product (outerwear and 'inner-wear') shipping in 2H07; and 3) increasing shipments in Europe (at least triple LY) led by the continued roll-out to 300 JJB stores in the U.K. In 2008, continued expansion in the outdoor category and Europe, plus the expected launch of sneakers (in both men's and women's) could support revenue growth above firm's +26% forecast.

BAC also expects UA's gross margins (after dropping in 1H07) to rise in 2H07 and up-tick further in 2008.

Notablecalls: Interesting comments buy BAC's Rober Ohmes. Note that international accounted for just 4% of revenues in 1Q07. Plenty of growth ahead for UA. The main problem here is the valuation. Trading 35-40x FY08, the stock's expensive meaning there is very little room for error. I think UA's one of the stocks you buy when they stumble.

In the very s-t, I think BAC's comments may generate some buy interest. But do note that the stock has bounced considerably over the past couple of days and some important averages (namely the 200 EMA) are near.

Citigroup comments on couple of fast movers

Citigroup is out with positive comments on couple of fast movers:

- First, they believe the recent pull back in Akamai (NASDAQ:AKAM) represents a buying opportunity. AKAM's 1Q results missed expectations but fundamentals were robust. Some investors were anticipating 1Q to be AKAMs 6th consecutive beat & raise qtr; results at the hi-end of guidance resulted in a ~20%+ drop in the shares.

Firm estimates AKAM's 07 rev and EPS growth at ~45% with 08 rev growth of 34% and EPS of 38%. Based on their ests, AKAM trades at a P/E of 34x 07 and 25x 08. If AKAM were to maintain its current 07 multiple on 08 ests it would yield a $59 share price or 37% higher than the current level. Citi thinks AKAM shares can provide an attractive return without exceeding current ests and expects the shares to rebound from current oversold condition.

AKAM competitor Limelight's pending IPO (S-1 filed March 22nd) will keep competition concerns top-of-mind but the firm thinks market demand and AKAM's differentiated offering will trump such worries.

- Secondly, coming out of restriction, Citi is updating their view on Riverbed (NASDAQ:RVBD) taking their rating to Buy from Hold. Post an impressive March and with a new product cycle at its back, the company's tech advantage is lengthening and momentum continues to build. Future catalysts include Steelhead Mobile, channel expansion, and an increased storage presence.

Riverbed continues on its hyper-growth track while progressing toward it starget operating model. While an opex catch-up may result in a margin pause for June, the company is on track to exit 2007 at ~20%+ Op Mgn vs the 20-25% LT target. Citi's prior CQ2 estimates of $43M and $0.07 are now $49M and $0.12. Tgt is raised to $52 from $34.

Notablecalls: Of the two calls, AKAM's certainly my favourite. The stock has been beaten down despite the fact nothing has really changed when it comes to fundamentals. The growth is still robust and we're yet to see any pricing pressure.

Paperstand (GE, IMCL, REGN, DNA, ONXX, KOG, CHC)

The WSJ reports that General Electric (GE) is close to agreeing to sell its plastics division for almost $11bn to Saudi Arabia's largest industrial co, Saudi Basic Industries. If the deal is completed, the Saudi co known will have bested Basell of Hoofddorp, after a long auction process. Several private-equity firms were also interested at one time.

„Heard on the Street” reports that shares of ImClone (IMCL) have tumbled more than 9% since Tuesday on heavy volume after embargoed data from an important cancer trial was released to 24K physicians expected to attend the conference of one of the largest oncology groups, the ASCO. Shares of Regeneron (REGN) have fallen almost 15% since and Genentech (DNA) is down 3%, while Onyx Pharma (ONXX) is up almost 10%, as investors pass around abstracts, or summaries, of data to be released as part of the ASCO meeting. Even though regulators have clamped down recently on co’s relaying mkt-moving information to select investors, it isn't the first time that stocks have moved sharply ahead of the key event, amid the growing hunger of investors to get an information edge on volatile stocks such as biotech co’s. "Oncology stocks consistently have shown unexplained volatility around the time ASCO releases data on embargo to its members," says Steven Harr, of Morgan Stanley.

Barron’s Online out saying that Kodiak (KOG) shares should scale new heights as the co plumbs the depths of the Rockies in search of untapped energy. The rocky shale Kodiak is drilling through is thousands of feet thick in the Vermillion Basin of Wyoming and Northern Colorado, far thicker than gas explorers usually encounter. Though it is more expensive and challenging to drill here than in most places on the continent, high gas flows from Kodiak's first wells and from those of another nearby energy-and-exploration co, Questar (STR), indicate that this region could become one of N-America's best natural-gas finds. Kodiak has yet to turn a profit, but the co is expected to start generating earnings once it shifts into production mode. Led by a cost-conscious mgmt team, each member with decades of energy experience in the Rockies, Kodiak has enough cash on the books to cover ‘07 operating costs. Speculators have driven Kodiak's shares from around $3 last fall to a record high $6.40 on May 1 on the two wells dug by Kodiak and a string of positive results from the area's largest player and first mover, Questar. Randall Abramson, of Trapeze Asset Mgmt, says Kodiak "is a very compelling resource story with a potential for an awful lot of natural gas." He sees the stock as a play on the potential value of reserves locked in Kodiak's land.

“Inside Scoop” section reprots that 4 insiders at Centerline (CHC) have been busy lining their coffers with shares of the co since the stock fell to a yearly low. CEO, Chmn, Vice Chmn and a managing trustee have bought a total of $9.3m of the co's stock since May 11. The cluster of purchases represents the highest level of quarterly buying at the co over the past 5 years. Stephen Ross, the co's non-exec Chmn, spent the most, buying 402K shares for $7.2m. Ross is "a legend in the real-estate business, so his involvement in [Centerline] and his buying here certainly makes it attractive," says Ben Silverman, of InsiderScore.com.

Thursday, May 17, 2007

MEMC (NYSE:WFR): Comments on buyback

- CIBC comments on MEMC (NYSE:WFR) after the co announced a much-anticipated share repurchase program for up to $500M of outstanding stock, though timing has not been disclosed.

Firm notes this is a definite positive for the shares, as investors have been anxiously awaiting a productive use of the ever-growing cash balance. At an avg. price of $60/share, the program would reduce share count by 8.33M shares, which if completed in 2008 would increase EPS estimate by $0.15, to $4.28 from $4.13. Based on CIBC's 19x target multiple, this could raise the calculated fair value of the shares by nearly $3, to $81. In the past 4 quarters, WFR has generated $457M of FCF, providing nearly all of the required funds for the share repurchase.

Firm believes the $500M authorization is larger than expectations, signaling optimistic prospects.

Notablecalls: The stock traded to $60 in after hours in reaction to the news. Looking at the chart, I feel there may be some more upside to WFR today. Just a gut feel, nothing more.

salesforce.com (NYSE:CRM): Growth becoming more expensive

Analysts are not too happy about salesforce.com's (NYSE:CRM) Q1 results:

- Morgan Stanley notes solid top line Q with upside to revenues but cash flow from operations was a little lighter than they anticipated and a significant increase in capitalized costs masked margin declines from their calculations. While the firm has readily acknowledged the significant growth of salesforce.com revenues, they remain concerned that the company is generating the growth at an increasing cost. They need to see better operating leverage - something that has yet to improve, and in fact may be weakening. Hence, they remain Underweight CRM shares.

- Cowen says they would not be surprised to see the stock trade off in the coming weeks following a decent, but not great quarter, in the face of high expectations and the looming specter of a full frontal assault by Oracle and Microsoft in the coming quarters. While most financial metrics were good, none were outstanding, and the company continues to be only marginally profitable on a GAAP basis. Despite a high level of predictability in the subs model, the firm believes heavy infrastructure investments intended to stimulate growth could have a negative impact on profitability and FCF should the competitive environment heat up, a scenario they consider highly likely. CRM trades at 38x Cowen's revised FCF forecast of $146M (+67%). Maintains Neutral.

Notablecalls: Well, it looks like growth is becoming more expensive for CRM. ORCL, MSFT and SAP have participated half-heartedly in the SAAS space so far but as Cowen notes, this may be changing soon. I don't think CRM's a core short here but it may see some downside over the next couple of days.

Paperstand (CCU, AAI, MEH, STI, COMS, JPM)

The WSJ reprots that strong momentum was building last night for a final plan to clinch the $19.4bn sale of Clear Channel (CCU) to a duo of private-equity firms. Major shareholders Highfields Capital Mgmt and Fidelity Investments were expected to be on board with a new buyout proposal brought forward last week. This proposal would sweeten the offer for the San Antonio media-and-entertainment co by 20c a share, to $39.20. The deal also offers current shareholders a chance to own as much as 30% of the newly constituted Clear Channel, which would be majority-owned by Bain Capital and Thomas H. Lee Partners. The shareholders' support for the plan clears the way for a deal that has endured months of contention among shareholders, the co's mgmt and the private-equity firms.

According to the WSJ, AirTran (AAI) is expected to announce that holders of almost 57% of the shares of Midwest Air (MEH) have agreed to sell their stock under AirTran's $389m offer to acquire the airline. B/c the support represents a shift in favor of its longstanding effort to purchase Midwest despite opposition from the rival carrier's board and mgmt, AirTran is also expected to extend the deadline for Midwest shareholders to tender their stock. Although AirTran's latest bid for Midwest expired at midnight yesterday, a new deadline is expected to be set for Jun. 8.

“Ahead of the Tape” column out saying that a wave of cash is looking for a home in the stock mkt. With Bausch & Lomb’s announcement yesterday that it had agreed to be taken private, there are now 12 co’s in the S&P500 index set to go private this year. The total price tag for these co’s stands at $179bn, according to S&P analyst Howard Silverblatt. That's a lot of cash investors will have to redeploy. "This is a lot of money that will have to find a home," Mr. Silverblatt says. S&P500 index funds will pump the money right back into stocks in the index, as will many of the actively managed mutual funds that use the index as a benchmark. First and foremost, they'll need to buy the shares of the co’s replacing the outgoing members of the index. Of course all the cash "coming" into the stock mkt was really the stock mkt's to begin with. The reality is that, with so many co’s going private, there are fewer stocks to buy, and that's sending the ones that remain higher.

“Heard on the Street” column reports that SunTrust Bank (STI) has sold 9% of its $2.3bn stake in Coca-Cola, and has said it will decide what to do with the rest by year's end. The move is meant to appease exasperated investors who see the Coke shares as an asset that SunTrust has been squandering for decades. Still, it could be too little too late to save SunTrust from a takeover long thought to be impossible. The bank's sale of the beverage maker's shares could make SunTrust more vulnerable, b/c any buyer of SunTrust currently would have to include the mkt value of the Coke holding in the purchase price. Shedding the stock would make a takeover of SunTrust less expensive, and some analysts have long argued that the Coke stake amounted to a "poison pill" that kept SunTrust in control of its destiny. "The clients who are holding the stock are the ones that believe there's going to be a deal," says Nancy Bush, of NAB Research, who has followed SunTrust closely for two decades. "It's very sad to me. This was once upon a time a great franchise."

Barron’s Online highlights 3Com (COMS), saying that the challenges to 3Com may be more than Citadel knows how to fix. Citadel upped its stake in 3Com from 1% to 8% in April, and has sent a note to the 3Com board offering to provide "input" to turn the stock around. The co's share of networking products has shriveled over the years dramatically. For 3Com to achieve sustained sales growth and profitability will be tough in a mkt where even Cisco is finding growth elusive. Worse, after taking sole control of the China venture, 3Com will end up with far less cash, a fact that gives value investors pause. Without that pristine balance sheet, 3Com looks more like an expensive networking stock trading at 25x next year's earnings. "It's difficult to see what Citadel could possibly do better than 3Com mgmt, at a time when the co is in transition, and given that networking is always competitive even for Cisco," says Mark Mowrey, of Al Frank Asset Mgmt. Mowrey is holding on to the stock for some upside potential, but "if I weren't already in the stock, I wouldn't put new money into it at this point," says Mowrey.

“Inside Scoop” section reprots that JP Morgan (JPM) is trading around all-time-high territory, and co insiders are celebrating the co's success by selling stock at a greatly increased pace. Over the past 30 days, execs have sold $14.4m in stock, comprising the majority of the $22.4m in stock sold over the last 2 years. The biggest sellers were CIO Ina Drew, and Steven Black, the co-CEO of JPM's investment-banking unit.

Wednesday, May 16, 2007

Motorola (NYSE:MOT): Comments on new products, restructuring and ESL

Several firms have commented on Motorola (NYSE:MOT) after the co a well-attended "Mobile Experience" meeting in New York. Following the product announcements, the company hosted a lunch meeting with CFO Tom Meredith:

- Raymond James maintains their Strong Buy rating saying that first and foremost, Motorola will become fixated on improving its cash conversion cycle, leaning down inventories, and better managing receivables and payables. The cFO indicated the company would announce additional downsizing and restructuring (likely to be announced May 30 or 31). While no details were provided on the magnitude of such a downsizing, he indicated the initial downsizing was not nearly significant enough.

In general, management seems to have regained confidence following the humbling experience of profit and market share losses in the March quarter, a sign the business may be stabilizing.

- CIBC notes they remain comfortable with their thesis and Sector Performer rating on the company. They are warming to the story, but are still looking for evidence of a clear turn and signs of market traction with the new 3G models (like the Z8, Q9, and RAZR2, which were highlighted at the event) before turning more positive. Firm believes the turn has come yet and comments by new CFO Thomas Meredith suggest 2Q07 trends remain very tough.

- Banc of America notes they believe the new products, with similar design but better features and functionality, are a step in the right direction. They are also encouraged by the new leadership, and expect Mr. Meredith to be a change agent. Firm believes MOT is moving up market at a time when the handset industry is transitioning to more fully featured products. They believe this tend is favorable for Nokia, Sony Ericsson, Research in Motion, Palm, and QUALCOMM.

Notablecalls: Nothing really unexpected emerged from the meeting. The RAZR2 is a cool phone but hardly a game changer. Heads have started to roll at MOT and according to whispers a merger of co's Networks and Connected Home business units will be announced soon. This will create some savings but as the CFO hinted, will likely be just the beginning. Which is positive, of course. Motorla has become too bloated and unfocused and now needs to correct itself.

On another matter, SEC filings published last night showed that Eddie Lampert, the billionaire hedge fund manager known for making large bets on a few companies, including Hoffman Estates-based Sears Holdings Corp, has acquired a 925,000 share stake in Motorola. Lampert received special permission from the SEC to postpone disclosing the details of some of his holdings. That "confidential treatment" expired last night. The filings also showed he poured close to $800 million into Citigroup stock and another $30 million into Clear Channel. Eddie didn't become rich by being stupid. It looks like his cost basis for MOT is pretty close to current market price. With Ichan and Lampert on board, I would not be surprised to see other big game hunters join soon.

Anyway, I continue to stand by my bullish thesis on Motorola.

Paperstand

The WSJ’s ”Ahead of the Tape” column reports that in the past few months, private-equity firms have been sizing up European insurers. Expectations are building in the stock mkt for deals and restructuring. Whether this leads to action remains to be seen, but already Europe's insurers are doing more to keep their shareholders happy. The Dow Jones Wilshire Global Insurance Index is up 6.55% this year. "Incumbent managers have an opportunity to create a lot of value," says Michael Huttner, a JP Morgan insurance analyst in London, adding that "managers might think if they don't hurry, it will be done for them." Only US listed co mentioned: Aegon (AEG).

“Inside Track” section out saying that not all stock purchases by CEOs are created equal, and a smaller purchase can sometimes be a better indicator than a larger one. John Riccitiello, the new CEO of Electronic Arts (ERTS), and W. Edward Scheetz, president and CEO of Morgans Hotel (MHGC), each bought shares of his co's stock last week, but the strength of the signal sent by the transactions differs significantly, said Jonathan Moreland, of InsiderInsights.com. Mr. Moreland said he finds Mr. Scheetz's purchase of $291K worth of Morgans Hotel stock a more positive sign than Mr. Riccitiello's purchase of almost $1m of EA stock, partly b/c of Mr. Scheetz's more timely trading history, and partly b/c of the recent runup in Morgans Hotel stock. "I was impressed that Mr. Scheetz was putting more money into a stock after it had risen so strongly in the past months," Mr. Moreland said. "I was also impressed with his track record, much more than with the gentleman at Electronic Arts."

Barron’s Online discusses Wyeth (WYE), whose shares closed at a 5-y high last week. It's no wonder. Despite the regulatory delays, Wyeth has one of the pharma industry's strongest pipelines. 2 or 3 potential blockbusters could hit the mkt by ‘08, and profits could beat expectations. Yet the stock trades at one of the lowest multiples in Big Pharma, and its performance YTD has lagged several of its peers. Thus, it wouldn't surprise us if the stock still has room to run. "The pipeline is strong and holds a lot of potential," says Herman Saftlas, of S&P. "Key drugs are doing well, and I forecast double-digit earnings growth, perhaps 10-11% annually over the next 2 years. Yet the stock trades at a discount to Big Pharma."

“Inside Scoop” section reprots that insiders at Blue Nile (NILE) have sold nearly $20m in stock since May 1, led by Chmn and CEO Mark Vadon and President, CFO and Director Diane Irvine. "When you look at the numbers," Ben Silverman, of InsiderScore.com, says, "these guys are taking some big profits now. It's well-deserved if you look at where stock has come from." As for investors, Silverman adds, "The signal is: Proceed with caution."

Tuesday, May 15, 2007

Amgen (NASDAQ:AMGN): Comments on Medicare NCD

Couple of firms comment on Amgen (NASDAQ:AMGN) after Medicare proposed a national coverage decision (NCD) to restrict reimbursement of Aranesp and Procrit for cancer:

- Goldman Sachs notes that assuming the limitations are implemented, except for MDS, Aranesp sales in 2008 might be reduced by 30% which is consistent with their 2007-09 forecast of $2.4bn (-13% yoy), $2.4bn (+ 0%), & $2.5bn (+1%), resp. Epogen sales would not be affected, but another proposed NCD is likely in 2007. They have assumed Epogen will decline by 4%, 14% & 10% in 2007-09, resp.

Despite the decline in Epogen & Aranesp sales, the firm expects 8-11% yoy EPS growth in 2007-09 due to expense control and share repurchase. Amgen shares are trading at 13X 2007 EPS (incl. ESO) & PEG of 1.5 based on 3-year EPS CAGR of 9%. The PE & PEG of drug stocks are 17X & 2.3, resp. GSCO's 12-month target of $72 is based on 16X Amgen's 2008 EPS of $4.50.

- Citigroup notes the proposal was published four months ahead of schedule after last week's FDA advisory panel meeting on the drugs. The scope and timing of the proposal will likely surprise investors and put downward pressure on Amgen.

In Citi's view, these reimbursement proposals could potentially restrict >50% of the CIA market depending on the final decision. The oncology segment represents ~17% of total Amgen?s sales. Thus, they see further downside to the stock relative to their $54 target price and expect Amgen to test the $50 support level.

They are very concerned that the FDA's Cardiorenal Advisory Committee in the fall will further vote to restrict usage of Epogen in the nephrology setting representing approximately 26% of Amgen's total sales. Thus, the firm continues to expect further weakness in the stock until CMS and FDA complete their review of the product labels and reimbursement in the nephrology setting.

Notablecalls: AMGN is down over 3 bucks in early action and I would not be surprised to see the stock hit $52 today. Would pick up some stock there for a bounce, as valuation is still cheap, despite the cuts.

Arris (NASDAQ:ARRS): How will it continue to grow?

- Raymond James is out with some cautious comments on Arris (NASDAQ:ARRS) noting that late last week, Liberty Global (LBTYA) posted March quarter telephony new net-adds (majority VoIP). The company signed on 172,000 telephony subscribers, up 3% from December. This compares to firm's 225,000 estimate. They view the March quarter results as lackluster and reinforce their view the majority of cable operators (which Arris serves) have hit steady state VoIP new net-adds. While healthy from a cable operator perspective, they view this trend as somewhat concerning for Arris's growth prospects.

Two of Arris's top four customers, Liberty Global and Time Warner (TWC), have reached what appears to be peak embedded multimedia terminal adaptor (E-MTA) volumes.

As it relates to Comcast (CMCSA), RJ estimates the operator will experience modest quarter / quarter growth the next three or four quarters and peak somewhere between 650,000 - 750,000 VoIP new net-adds per quarter (up from 571,000 in March). While impressive from an operator perspective, given an E-MTA average selling price of $70-$80 (and falling over time), the firm is hard pressed to understand how Arris will continue to grow its E-MTA revenue base meaningfully.

Notablecalls: ARRS' business is about 1/3 CMTS (cable modem termination systems) and 2/3 eMTA (embedded multimedia terminal adaptor). CMCSA accounts for roughly 40% of revs.

The CMTS side carries high margins but the margins have likely peaked already and are likely to decline from here. CSCO and MOT are likely to regain share over the next couple of yrs.

It also looks like the eMTA side is no longer high growth territory. Trading 18x 08 EPS, ARRS doesn't really look like a bargain here.

Monday, May 14, 2007

Motorola (NYSE:MOT): Mid-quarter checks suggest some stabilization

- CIBC comments on Motorola (NYSE:MOT) saying their mid-quarter checks suggests MOT has managed to stabilize its handset market share in most regions, yet in Asia inventories remain high and continue to make an impact on sell-in. Given Asia's impact on MOT, they are lowering their shipments target in 2Q07 to 44.5M (-2% QoQ) from 46M.

Firm notes they have seen evidence of two trends that illustrate the progress MOT is making internally to address its issues. Adoption of a firm global pricing policy (and adhering to it). A shake up in the global distribution system, reducing arbitrage activity and forcing regional sell-through disciplines.

MOT will host an event on May 15 in which it will show a mix of already introduced models and new models, including new derivatives of the MOTOFONE and a new slick RAZR-like clamshell. CIBC expects features to still be light, and would keep expectations low. Looks for late '07 for change.

The firm is tweaking their estimates to reflect more near-term sell-in challenges. For 2Q07, they are slightly reducing revenue estimate to $9.2 billion from $9.4 billion. Pro forma EPS estimate is unchanged at $0.04. They are looking for a clear turn and new 3G models before turning more positive.

Notablecalls: Nice comments by CIBC's Ittai Kidron. Zander and his team are trying to fix the problems ailing MOT's largest division - the mobile. While the pricing and distrubution system are important, I think what investors really want to hear is that the mobile poducts development labs are working feverishly to come up with new and cool products. There has been some ga-ga over the RIZR R8 lately but looking at the thing..it looks like all the other phones out there.

The stock is starting to look good. In fact, it looks like it cleared the 50 day EMA on Friday. The last time MOT closed above this average was in October 2006. I continue to stand by my bullish thesis on MOT.

Sandisk (NASDAQ:SNDK): May have some s-t upside in it

- Citigroup is positive on Sandisk (NASDAQ:SNDK) saying QTD NAND contract pricing action augments near-term plusses (margin and expense related upside potential) and intermediate-term catalysts (pos 2H07 est revisions and multiple expansion), bolstering conviction in their call.

Tactically, they advise investors to build positions patiently thru the Q on market volatility (for now less urgency needed than in analog Co's ADI, ISIL, FCS and SMTC). NAND contract pricing was stable in 1H May and overall densities are tracking flat QTD with 4Gb+ up 10% (vs 1Q averages). While the firm expect a modest June swoon (seasonality), prospects are increasing better-than-modeled 2Q07 pricing (-5% embedded in their 3Q07 royalty calculation). Recalls Samsung/Hynix guided to +20% 2Q pricing).

Citi remains confident NAND fundamentals can move into under-supply by late-3Q. Upcoming milestones impacting sector psychology include: 1) MOT's 5/15 new product launch (embedded/removable NAND demand), 2) Bi-monthly contract pricing updates 3) Monthly US retail card/drive/MP3 sell-through date (released the last week of each Q (NPD/CIR)), and 4) Apples's late-June iPhone aunch (embedded/removable NAND demand).

Notablecalls: Well, SNDK's chart looks good. May have couple of bucks of upside in it if it gets moving. One to watch.

Paperstand

The WSJ reports that DaimlerChrysler (DCX) is expected to announce as early as today a deal to sell a controlling stake in Chrysler Group to private-equity firm Cerberus Capital Mgmt. The proposed deal would allow the auto giant to shed Chrysler's $18bn in retirement and health-care liabilities and could open the door to further restructuring of the nation's unionized auto makers. Under the proposed deal, Chrysler Chief Executive Tom LaSorda would continue to run the company.

According to the WSJ, the Army is pushing to turn a crowded multibillion-dollar competition for the next generation of troop transports into something closer to a winner-take-all event. Now that the Pentagon is planning on buying many more of the vehicles, Army officials say they would like to see one primary design. That would make the vehicle much easier to maintain. "If you have four different vehicles, that means you have to have four different logistics systems to provide parts. You have to train soldiers how to fight from four different vehicles. It becomes very expensive and complex," the senior Army official said. US Central Command say that it now needs as many as 17,700 vehicles, enough to ensure that every soldier who leaves the base in Iraq is riding in one of them. The surge in demand has forced the smaller players, such as Force Protection (FRPT), to team up with major vehicle producers to increase production. Mike Aldrich, VP of business development and govt relations, said the Force Protection-General Dynamics (GD) joint venture could produce more than 10K MRAP vehicles by the end of ‘08. "What's holding us back is a substantial order," he said. Oshkosh Truck (OSK) has also entered the fray.

“Ahead of the Tape” out saying that if the housing-mkt shakeout has an epicenter, it probably lies in Florida. For co’s with business tied closely to the state, that is a problem. Home builders are getting hit hardest in Florida. Building permits for new-home construction were 51% below their year-ago level in the 1Q. Florida still boasts one of the lowest unemployment rates in the country. But it wouldn't be surprising to see its broader economy worsen in the mo’s ahead. Big public builders have established an outsized presence in Florida. Co’s that supply builders are feeling pinched. PGT (PGTI) generated 92% of its business in Florida last year. In the 1Q, PGT's sales were down 25%. Florida Rock (FRK) reported that 1Q sales were down 33%. Banks with exposure to Florida real estate have been getting hurt, even some far away from the state. In April, Webster Financial (WBS) warned that credit quality on its Florida residential-construction loan portfolios had deteriorated. Retailers with big exposure to the state could suffer, too. MarineMax (HZO) has been lowering its sales expectations. It generates more than 40% of its sales in Florida. Haverty Furniture (HVT) has said its sales in Florida are getting hurt by the combination of the housing downturn, rising insurance rates and rising property taxes charged to out-of-state residents. Florida has little in the way of exports, and so it is unlikely to get much help from strong global economic growth, says Goldman economist Jan Hatzius. He doesn't think the housing downturn is enough to push the whole US economy into recession, but it could be a "canary in the coal mine" of trouble in regional economies.

Sunday, May 13, 2007

Barron's Summary

Barron’s cover lines up Top500 co’s based on cash-flow returns on investment. This year top honors go to Goldman Sachs ( GS), Franklin Resources (BEN) ranks 2nd. The bronze went to Apple (AAPL), while Terex (TEX), took fourth place, and Paccar (PCAR) fifth.

Barron’s interviewed analyst likes NUE, RS, STLD and AKS. Another fund manager top10 holdings include PENN, AMT, MKL, KMX, POOL, NDN, PNK, BYI, ACF and GISX.

If the merger of Thomson (TOC) and Reuters (RTRSY) goes through as planned, resulting cash flows could make Thomson shares worth roughly 20% more than Friday's level.

The Dolans, controlling shareholders of Cablevision (CVC), have offered $36-and-change fore share that now tade above 35. Dissenting shareholders say the company is worth $50 to $60 a share. "We'd hang in until [the Dolans] force us out," says Christopher Marangi, of Gamco Investors.

With lower interest rates, Annaly Capital Mgmt (NLY) could earn more than $2 a share, which could propel its stock into the low-20s. Some savvy investors now think the worst is over. "The yield curve will start to steepen in the 2H07 and continue to do so in '08 as the economy begins to slow and the Fed cuts rates," says Arnie Schneider, CIO of Schneider Capital Mgmt.

The shares of Constellation Brands (STZ) are starting to recover after a sharp drop earlier this year. As the company tends to its challenges, the shares could jump more than 25% in a year. Tim Ramey, of DA Davidson, sees profits climbing 20% in F'09, to $1.75 a share. The shares, now trading at just 13.5x that est, could well hit 29 in 12-18 months, he says.

“The Trader” column discusses Virgin Media (VMED), whose shares trade at a big discount to their US counterparts. Virgin's shares have long attracted hedge funds with a keen nose for bargains. To Brad Ruderman, of Ruderman Capital Mgmt, Virgin's selloff last week illustrates the "very, very tight leash granted to mgmt" by Wall St, after predecessor NTL had loaded the co with debt to build its infrastructure. "But what was negative for the previous regime is now positive for the co," Ruderman says. "It has a state-of-the-art network already in place, and now it's up to mgmt to monetize the value of that network." He reckons shares are worth at least 35, with Virgin's cash flow and dominant network also enticing to buyout firms. Drawing parallels between UK and US cable businesses can seem as absurd as, well, comparing soccer and football. But at about 24, Virgin shares trade at just 6.4x ‘07 operating cash flow, compared with multiples of 8-9 for stateside counterparts, says Oppenheimer analyst Thomas Eagan. He calls the stock's pullback "overdone" and says "now is the time to buy."

“The Trader” also out saying that the selling in the shares of Dean Food (DF) may be overdone. The shares seem to have discounted a worst-case scenario, making valuation more compelling. Mgmt had guided ‘07 profits to $1.72 a share, the low end of its forecast range. Jim Lane, of TriPoint Asset Mgmt, also sees limited downside. If shares slide toward, say, 25, an earnings yield approaching 6.6% could make Dean a tgt for larger food co’s. If dairy margins firm up, the shares could trade up to 42.

“Technology Trader” section discusses Seagate (STX) and Western Digital (WDC), whose shares are down 16% and 11% respectively, YTD. Some analysts have even suggested that flash memory could completely replace drives in PCs, and put Western and Seagate out of business. But PC sales are doing just fine, and flash - in great part owing to its cost - is not going to replace disk drives globally for years to come. Once investors come to appreciate those facts, Western Digital shares could appreciate another 20% or more. Western is cheaper than Seagate by a wide margin, trading at a 2-y-low P/E multiple of about 9.4x the next four quarters' estd profit, below its 5-y median of 11.6x, while Seagate is near its median of 12.2x. "Western has an attractively valued stock for a co that is one of the premier players in a mkt that's set to grow at least 10% a year for several years," says Citigroup analyst Paul Mansky, referring to the expected ramp-up in disk-drive unit sales. Mansky thinks that Western Digital is "a technology laggard by design," and that some investors underestimate Western Digital's strategy of gaming the technology curve to turn in profits and steady cash flow.